The Roth lab at Stanford University focuses on engineering human cells for therapeutic applications, particularly in cancer treatment. They aim to create new cell states that can enhance the function of primary human T cells using advanced genetic modifications. By leveraging cutting-edge technologies such as CRISPR, the lab explores how to produce new non-evolved human genes to optimize immune responses against tumors.

Dr. Matthew J.M. Rowan's lab at Emory University focuses on the intricate biology of Alzheimer's disease, particularly how specific brain cells called parvalbumin-expressing interneurons malfunction as the disease progresses. Using advanced robotic technology, his team examines how these cellular changes correlate with cognitive decline and the early indicators of Alzheimer's. The ultimate goal is to develop innovative therapeutic strategies to address circuit dysfunction and improve outcomes for patients with dementia.

Dr. Megan K Ruhland's lab at Oregon Health & Science University studies how male and female immune systems respond differently to cancer, especially in melanoma. The lab focuses on understanding how androgen receptors in specific immune cells called dendritic cells influence the body's ability to fight tumors. By using innovative mouse models, the team aims to uncover how these differences impact T cell activation and vaccine effectiveness against cancer.

Kristy Stengel's lab focuses on understanding how the RUNX1 transcription factor regulates the development of blood cells and its links to blood disorders, such as familial platelet disorder and blood cancer. The lab utilizes innovative techniques to examine how RUNX1 interacts with other proteins to control gene expression that is critical for blood cell formation and function. By employing cell lines and engineered mouse models, they aim to uncover the mechanisms behind RUNX1's role in hematopoiesis, contributing to our understanding of genetic blood conditions.

Dr. Bernardo L. Sabatini's lab focuses on understanding how the brain's neurotransmitter signals, especially dopamine, influence decision-making and behavior. The research investigates how different types of dopamine signaling operate, impacting learning and memory, as well as exploring the complexities of synaptic transmission in the brain. By studying these processes in mice, the lab aims to uncover mechanisms related to neuropsychiatric diseases and improve our understanding of brain function.

Dr. Jonah B. Sacha's lab focuses on understanding how certain immune responses can lead to the cure of HIV. By studying the effects of allogeneic hematopoietic stem cell transplantation in both cured HIV patients and macaques, the lab aims to uncover specific T cell responses that can effectively eliminate the viral reservoir. Their research has significant public health implications, as it could lead to new therapeutic methods for HIV treatment.

Dr. Junichi Sadoshima's lab at Rutgers focuses on understanding the cellular processes that contribute to heart aging and failure. The research emphasizes how aging affects heart cells, particularly through mechanisms like cellular senescence and oxidative stress, leading to heart disease. By studying the roles of autophagy and cysteine oxidation in cardiac cells, the lab aims to uncover potential strategies to improve heart health and longevity.

Dr. Jeroen Saeij's lab at UC Davis focuses on understanding how the Toxoplasma gondii parasite survives and grows in human cells, particularly in individuals with weakened immune systems. The lab investigates how human immune responses, including certain cytokines like interferon and tumor necrosis factor, can inhibit Toxoplasma growth, and how the parasite counters these defenses. Through advanced techniques like CRISPR screens, the research aims to identify potential new treatments for toxoplasmosis and to better predict which Toxoplasma strains may be more virulent in humans.

Dr. Yogesh Saini's lab at North Carolina State University focuses on understanding how air pollution, particularly ozone, affects allergic asthma. They study the biological processes involved in the inflammation and healing of respiratory conditions. By investigating specific signaling pathways, the lab aims to find new ways to treat and manage respiratory diseases linked to air pollution and allergies.

Dr. Marco Salemi's lab focuses on understanding how SARS-CoV-2 evolves in people with compromised immune systems, specifically those with HIV. They develop advanced computational tools using artificial intelligence to predict which viral variants might emerge and spread. This research is crucial for improving public health responses to ongoing and future COVID-19 challenges.

Dr. Kelly T. Hughes' lab at the University of Utah focuses on understanding how bacteria, particularly Salmonella, use specialized structures called injectisomes to infect host cells. By studying the intricate processes that allow these bacteria to deliver harmful proteins into cells, the lab aims to develop new ways to combat bacterial infections and address the growing problem of antimicrobial resistance. The research not only sheds light on basic biological mechanisms but also seeks to uncover potential targets for new therapeutic strategies.

Dr. Carlos Sanchez Moreno's lab focuses on understanding the racial disparities in prostate cancer, particularly how the disease affects African-American men compared to European-American men. The research investigates the roles of specific genes and metabolic pathways in the progression and metastasis of prostate cancer. By uncovering the biological mechanisms behind these health disparities, the lab aims to develop targeted therapies that could help reduce cancer mortality rates in diverse populations.

Dr. Vijayalakshmi Santhakumar's research lab at UC Riverside focuses on understanding the dentate gyrus region of the brain, which plays a crucial role in memory processing. Their work investigates how certain types of inhibitory neurons affect memory functions, especially in the context of neurological disorders like temporal lobe epilepsy. By exploring alterations in circuit mechanisms caused by epilepsy, the lab aims to uncover insights that could inform treatments for cognitive deficits, contributing to our understanding of memory decline in aging and diseases like Alzheimer's.

Dr. Ansuman Satpathy's lab at Stanford University focuses on creating detailed maps of genetic regulatory elements in human immune cells. By using advanced single-cell technology, the lab studies how these elements behave during different life stages and across various diseases, including cancer and autoimmune conditions. Their work aims to improve our understanding of how genetic differences can affect health and disease.

Dr. Thomas F Schilling's lab at UC Irvine investigates how cells organize themselves during the development of the skeleton, particularly focusing on craniofacial bones. They aim to understand the signals that guide cartilage growth and alignment, which is crucial for normal bone formation. Insights from this research could lead to better treatments for skeletal disorders and congenital malformations.

Dr. Susan Ruth Schwab's research focuses on understanding how T cells exit from sites of inflammation, which is crucial for immune responses. By exploring the role of specific lipids in guiding T cell movement, her lab aims to uncover mechanisms that could prevent T cell exhaustion and improve memory responses during chronic inflammation. They utilize a novel mouse model to manipulate gene expression in a targeted manner, enabling detailed studies of T cell behavior in real time.

Dr. Kathryn Schwertfeger's research lab at the University of Minnesota focuses on breast cancer, specifically how immune cells, particularly macrophages, interact with tumors. The lab investigates signaling pathways that affect macrophage behavior, aiming to enhance the body’s anti-tumor immune response. By understanding how these pathways work, the research hopes to develop new treatments that can improve cancer outcomes for patients.

Dr. Patrick Seale's lab focuses on understanding how fat tissue changes during obesity and the impact this has on health. They study specific cells in fat tissue called mesenchymal progenitor cells, which can switch their roles and promote inflammation when the body is under stress from excess weight. This research is crucial for finding new ways to treat obesity-related diseases like diabetes and heart disease.

Dr. Selenica's lab focuses on understanding the role of a specific protein modification in brain diseases like Alzheimers and related dementias. They investigate how this modification affects a protein called TDP-43, which is linked to cognitive decline. The research aims to uncover how changes in TDP-43 contribute to neurological disorders, providing insights that could lead to new therapeutic approaches.

Dr. Subrata Sen's lab focuses on advancing the early detection of pancreatic cancer, a particularly aggressive form of cancer. The researchers are developing and validating blood-based biomarkers and advanced imaging techniques to identify the disease at an earlier stage, using both machine learning and multiple biological analyses. Their work aims to improve risk assessment and provide better options for patients at high risk of developing pancreatic cancer.